The Janssen Pharmaceutical Companies of Johnson & Johnson, one of the world’s largest healthcare companies, has been operating in Türkiye for 23 years and continues to support the development areas of its employees.
As part of this effort, Berkin Gökbudak, who has served as the Business Unit Director for Oncology-Hematology and Pulmonary Hypertension in Janssen Türkiye and Ukraine, has been appointed as the EMEA Region Commercial Strategy Senior Director for the Neuroscience and Pulmonary Hypertension units.
Gökbudak has played a pivotal role in achieving notable successes alongside the Hematology, Oncology, and Cardiology teams he leads at Janssen Türkiye. In his new position, he will be responsible for formulating and executing the EMEA region’s commercial strategy for Neuroscience and Pulmonary Hypertension.
Laetitia Decroix Guilloux, the General Manager of Janssen TURGAN, which has been recognized as the Best Employer for the third consecutive time by the independent assessment organization Top Employers Institute for the support it provides to employees, stated, “In today’s highly competitive markets, we are aware that we need to support our employees in all areas to create the ideal working environment. We include our colleagues in all processes we carry out with an innovative perspective and continue to support them globally. As Johnson & Johnson, we are committed to providing unique opportunities for career development to our employees who continue their careers in new markets and positioning Türkiye as a talent center for Johnson & Johnson.”
